Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Neurourol Urodyn ; 42(1): 23-32, 2023 01.
Article in English | MEDLINE | ID: mdl-36378811

ABSTRACT

INTRODUCTION: Intradetrusor BotulinumtoxinA (BTA) injections are recommended for patients with overactive bladder (OAB) refractory to lifestyle changes and medical intervention. It is preferable to perform injections using a flexible cystoscope under local anesthetic (LA) rather than under spinal or general anesthetic owing to the associated anesthetic risks, increased costs, and need for repeated inpatient admission. Injections under LA can be difficult to tolerate for some patients. This review aims to assess interventions that may improve the tolerability of intradetrusor BTA injections under LA. METHODS: A systematic review was performed using Ovid of Embase + Embase classic and MEDLINE® ALL in November 2021. Articles were included if they reported objectively measured pain scores during LA intradetrusor BTA injections for refractory OAB. The risk of bias was assessed using Cochrane risk of bias tools. Meta-analysis was not performed owing to the heterogeneity of outcome measures. RESULTS: Ten studies were included in this review with a total of 429 participants. The review identified alkalinized lidocaine, electromotive drug administration (EMDA), opiate suppositories, lidocaine bladder instillations, number of injections, and dose of BTA as interventions aimed at improving tolerability. CONCLUSION: EMDA of intravesical alkalinized lidocaine, intravesical, alkalinized lidocaine without EMDA, and a reduction in the number of injection site were all associated with improvements in patient tolerability during LA BTA injections. Further research should address which subgroups of patients find the procedure most painful and would benefit most from these interventions.


Subject(s)
Botulinum Toxins, Type A , Neuromuscular Agents , Urinary Bladder, Overactive , Humans , Anesthetics, Local , Botulinum Toxins, Type A/therapeutic use , Urinary Bladder, Overactive/drug therapy , Lidocaine , Administration, Intravesical , Neuromuscular Agents/therapeutic use
2.
Int J Qual Health Care ; 35(1)2023 Mar 16.
Article in English | MEDLINE | ID: mdl-36857374

ABSTRACT

Last-minute cancellations in urological surgery are a global issue, resulting in the wastage of resources and delays to patient care. In addition to non-cessation of anticoagulants and inadequately treated medical comorbidities, untreated urinary tract infections are a significant cause of last-minute cancellations. This study aimed to ascertain whether the introduction of a specialist nurse clinic resulted in a reduction of last-minute cancellations of elective urological surgery as part of our elective recovery plan following the Coronavirus disease 2019, the contagious disease caused by severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2 pandemic. A specialist urology nurse-led clinic was introduced to review urine culture results preoperatively. Specialist nurses contacted patients with positive urine cultures and their general practitioners by telephone and email to ensure a minimum of 2 days of 'lead-in' antibiotics were given prior to surgery. Patients unfit for surgery were postponed and optimized, and vacant slots were backfilled. A new guideline was created to improve the timing and structure of the generic preassessment. Between 1 January 2021 and 30 June 2021, a mean of 40 cases was booked each month, with average cancellations rates of 9.57/40 (23.92%). After implementing changes on 1 July 2021, cancellations fell to 4/124 (3%) for the month. On re-audit, there was a sustained and statistically significant reduction in cancellation rates: between 1 July 2021 and 31 December 2021 cancellations averaged 4.2/97.5 (4.3%, P < .001). Two to nine (2%-16%) patients were started on antibiotics each month, while another zero to two (0%-2%) were contacted for other reasons. The implementation of a specialist urology nurse-led preassessment clinic resulted in a sustained reduction in cancellations of last-minute elective urological procedures.


Subject(s)
COVID-19 , Humans , COVID-19/epidemiology , SARS-CoV-2 , Elective Surgical Procedures , Ambulatory Care Facilities , Appointments and Schedules
3.
Int Braz J Urol ; 43(3): 394-406, 2017.
Article in English | MEDLINE | ID: mdl-28338301

ABSTRACT

BACKGROUND: Shock wave lithotripsy (SWL) is the first line treatment modality for a significant proportion of patients with upper urinary tracts stones. Simple analgesics, opioids and non-steroidal anti-inflammatory drugs (NSAIDs) are all suitable agents but the relative efficacy and tolerability of these agents is uncertain. OBJECTIVES: To determine the efficacy of the different types of analgesics used for the control of pain during SWL for urinary stones. MATERIALS AND METHODS: We searched the Cochrane Renal Group's Specialised Register, MEDLINE, EMBASE and also hand-searched reference lists of relevant articles (Figure-1). Randomised controlled trials (RCT's) comparing the use of any opioid, simple analgesic or NSAID during SWL were included. These were compared with themselves, each-other or placebo. We included any route or form of administration (bolus, PCA). We excluded agents that were used for their sedative qualities. Data were extracted and assessed for quality independently by three reviewers. Meta-analyses have been performed where possible. When not possible, descriptive analyses of variables were performed. Dichotomous outcomes are reported as relative risk (RR) and measurements on continuous scales are reported as weighted mean differences (WMD) with 95% confidence intervals. RESULTS: Overall, we included 9 RCTs (539 participants from 6 countries). Trial agents included 7 types of NSAIDs, 1 simple analgesic and 4 types of opioids. There were no significant differences in clinical efficacy or tolerability between a simple analgesic (paracetamol) and an NSAID (lornoxicam). When comparing the same simple analgesic with an opioid (tramadol), both agents provided safe and effective analgesia for the purpose of SWL with no significant differences. There were no significant differences in pain scores between NSAIDs or opioids in three studies. Adequate analgesia could be achieved more often for opioids than for NSAIDs (RR 0.358; 95% CI 043 to 0.77, P=0.0002) but consumed doses of rescue analgesia were similar between NSAIDs and opioids in two studies (P=0.58, >0.05). In terms of tolerability, there is no difference in post-operative nausea and vomiting (PONV) between the groups (RR 0.72, 95% CI 0.24 to 2.17, P=0.55). One study compared outcomes between two types of NSAIDs (diclofenac versus dexketoprofen). There were no significant differences in any of our pre-defined outcomes measures. CONCLUSION: Simple analgesics, NSAIDs and opioids can all reduce the pain associated with shock wave lithotripsy to a level where the procedure is tolerated. Whilst there are no compelling differences in safety or efficacy of simple analgesics and NSAIDs, analgesia is described as adequate more often for opioids than NSAIDs.


Subject(s)
Analgesia/methods , Analgesics, Opioid/administration & dosage , Analgesics/administration & dosage , Lithotripsy/adverse effects , Urinary Calculi/surgery , Analgesics/classification , Humans , Pain, Postoperative/drug therapy
4.
Urol Case Rep ; 50: 102470, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37455779

ABSTRACT

Holmium laser enucleation of the prostate (HoLEP) is the preferred technique for surgical management of benign prostatic hyperplasia in prostates over 80 cc in size. A 72-year-old male underwent a HoLEP for catheter-dependent urinary retention in the context of a 204 cc prostate. At the end of the procedure he was clinically overloaded and had developed a combined respiratory and hyperchloremic normal anion gap metabolic acidosis secondary to excessive absorption of normal saline irrigation fluid. He was transferred to the ICU for diuresis and supportive care where he made a full recovery.

5.
J Surg Case Rep ; 2022(6): rjac275, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35712611

ABSTRACT

We report on a 79-year-old male patient who presented with asymptomatic elevation of prostate-specific antigen and a concurrent papillary lesion, which raised the suspicion of synchronous bladder and prostatic malignancies. He underwent a trans-perineal prostate biopsy as well as transurethral resection of bladder tumour, which revealed a Gleason 9 adenocarcinoma of prostatic origin. While synchronous bladder and prostate cancer is a possibility, differential diagnosis in a patient presenting with lesions of the bladder neck should include advanced prostate cancer.

6.
Cureus ; 14(10): e30922, 2022 Oct.
Article in English | MEDLINE | ID: mdl-36465783

ABSTRACT

A very rare complication of robot-assisted laparoscopic radical prostatectomy (RALP) is bladder stone formation from a hemostatic clip as a nidus. A 70-year-old man presented 11 years after a RALP with recurrent UTI, worsening lower urinary tract symptoms, and visible haematuria. A flexible cystoscopy revealed a large 3.5 cm x 1.5 cm stone at the bladder neck. Computed Tomography (CT) Urogram revealed normal kidneys with no hydronephrosis and a bladder stone. The patient underwent a cystolithotripsy as a day case which was performed by use of Swiss LithoClast® Trilogy lithotripter, which delivered controlled ultrasonic and ballistic energy and simultaneous suction through a single probe. Hemostatic clips were incidentally identified during the procedure and were successfully removed. The patient was discharged on the same day and made an excellent recovery. Hence, migration of clips is a rare occurrence, and good intraoperative techniques should avoid such complications to occur.

7.
J Endourol Case Rep ; 6(2): 70-72, 2020.
Article in English | MEDLINE | ID: mdl-32775681

ABSTRACT

Background: Urethral catheterization is a common procedure, with a low complication rate. Aberrant catheterization into a ureter is a rare complication. We present a case of an aberrant urethral catheterization into the right ureter in a postpartum female. Case Presentation: An 18-year-old primigravida female presented with loin pain and catheter bypassing after a postpartum urethral catheterization. Examination under anesthesia and cystoscopy revealed the catheter leading into the right ureter, which was confirmed by subsequent CT urogram. Multiple attempts to remove the catheter failed. A rigid ureteroscopy was performed, revealing "kinking" of the catheter just distal to the balloon, as a result of an asymmetrical inflated balloon. A laser fiber inserted through the ureteroscope punctured the balloon, allowing balloon deflation and catheter removal under screening. A relook ureteroscopy 8 weeks later confirmed a healed ureter. Conclusion: Asymmetric catheter balloon inflation causes kinking of a catheter and occlusion of the balloon port that will prohibit balloon deflation. During rigid ureteroscopy, a laser fiber can be used to puncture the catheter balloon, allowing balloon deflation and catheter removal.

8.
Clin Gastroenterol Hepatol ; 7(11): 1189-94, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19426836

ABSTRACT

BACKGROUND & AIMS: Primary (idiopathic) bile acid malabsorption (BAM) is a common, yet underrecognized, chronic diarrheal syndrome. Diagnosis is difficult without selenium homocholic acid taurine (SeHCAT) testing. The diarrhea results from excess colonic bile acids, but the pathogenesis is unclear. Fibroblast growth factor 19 (FGF19), produced in the ileum in response to bile acid absorption, regulates hepatic bile acid synthesis. We proposed that FGF19 is involved in bile acid diarrhea and measured its levels in patients with BAM. METHODS: Blood was collected from fasting patients with chronic diarrhea; BAM was diagnosed by SeHCAT. Serum FGF19 was measured by enzyme-linked immunosorbent assay. Serum 7alpha-hydroxy-4-cholesten-3-one (C4) was determined using high-performance liquid chromatography, to quantify bile acid synthesis. Data were compared between patients and subjects without diarrhea (controls). Samples were taken repeatedly after meals from several subjects. RESULTS: The median C4 level was significantly higher in patients with primary BAM than in controls (51 vs 18 ng/mL; P < .0001). The median FGF19 level was significantly lower in patients with BAM (120 vs 231 pg/mL; P < .0005). There was a significant inverse relationship between FGF19 and C4 levels (P < .0004). Low levels of FGF19 were also found in patients with postcholecystectomy and secondary bile acid diarrhea. Abnormal patterns of FGF19 levels were observed throughout the day in some patients with primary BAM. CONCLUSIONS: Patients with BAM have reduced serum FGF19 which may be useful in diagnosis. We propose a mechanism whereby impaired FGF19 feedback inhibition causes excessive bile acid synthesis that exceeds the normal capacity for ileal reabsorption, producing bile acid diarrhea.


Subject(s)
Bile Acids and Salts/biosynthesis , Bile Acids and Salts/toxicity , Diarrhea/chemically induced , Fibroblast Growth Factors/blood , Malabsorption Syndromes/pathology , Cholestenones/blood , Chromatography, High Pressure Liquid , Enzyme-Linked Immunosorbent Assay/methods , Feedback, Physiological , Female , Humans , Male , Middle Aged , Models, Biological , Serum/chemistry , Taurocholic Acid/analogs & derivatives
9.
Eur J Gastroenterol Hepatol ; 20(5): 413-22, 2008 May.
Article in English | MEDLINE | ID: mdl-18403943

ABSTRACT

OBJECTIVES: Chronic diarrhoea resulting from primary idiopathic bile acid malabsorption (IBAM) is common, but its aetiology is largely unknown. We investigated possible mechanisms, first looking for common sequence variations in the cytoplasmic ileal bile acid-binding protein (IBABP, gene symbol FABP6), and secondly, determining the expression of ileal mucosal transcripts for the apical sodium-linked bile acid transporter (ASBT), IBABP, the putative basolateral transporters, OSTalpha and OSTbeta, and regulatory factors. METHODS: Genomic DNA was prepared from two cohorts of patients and two control groups; the promoter and exonic regions of FABP6 were sequenced. In intestinal biopsies, transcript expression was measured by quantitative real time-PCR, using ileum from 17 patients and 21 controls. RESULTS: Sequence variations were identified in FABP6, but overall frequencies were similar in patients and controls. Transcripts of ASBT and IBABP, but not OSTalpha and OSTbeta, were expressed at higher levels in ileum than duodenum. The transcription factors farnesoid-X-receptor (FXR) and liver-receptor-homologue (LRH-1) were also more abundant in ileum, as was fibroblast growth factor 19 (FGF19), unlike short heterodimer partner (SHP), c-Fos, or CDX2. No significant differences in mean or median values were found between the groups for any of these transcripts. However, findings on regression analysis suggested that these transporters differ in their regulation, particularly in the relationships of CDX2, LRH-1 and FXR with OSTalpha. CONCLUSION: Most cases of IBAM are unlikely to be caused by genetic variation in FABP6 or by major differences in transporter transcript expression. Our evidence indicates that other factors, such as regulation of expression of the basolateral bile acid transporter, should be considered as possible causes.


Subject(s)
Bile Acids and Salts/metabolism , Carrier Proteins/metabolism , Diarrhea/metabolism , Ileum/metabolism , Malabsorption Syndromes/metabolism , Membrane Glycoproteins/metabolism , Adult , Aged , Carrier Proteins/genetics , Chronic Disease , Diarrhea/etiology , Fatty Acid-Binding Proteins/genetics , Female , Fibroblast Growth Factors/metabolism , Gastrointestinal Hormones/genetics , Gene Expression Regulation , Gene Frequency , Humans , Intestinal Mucosa/metabolism , Malabsorption Syndromes/complications , Malabsorption Syndromes/genetics , Male , Membrane Glycoproteins/genetics , Middle Aged , Polymorphism, Single Nucleotide , Prospective Studies , Transcription Factors/metabolism
10.
J R Soc Med ; 111(4): 125-135, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29648512

ABSTRACT

Over the last thirty years, the management of Malignant Ureteric Obstruction (MUO) has evolved from a single disciplinary decision to a multi-disciplinary approach. Careful consideration must be given to the risks and benefits of decompression of hydronephrosis for an individual patient. There is a lack of consensus of opinion as well as strong evidence to support the decision process. Outcomes that were identified amongst patients undergoing treatment for MUO included prognosis, quality of life (QOL), complications, morbidity and prognostication tools. A total of 63 papers were included. Median survival was 6.4 months in the 53 papers that stated this outcome. Significant predictors to poor outcomes included low serum albumin, hyponatremia, the number of malignancy related events, and performance status of 2 or worse on the European cooperative cancer group. We propose a multi-centre review of outcomes to enable evidence-based consultations for patients and their families.


Subject(s)
Decompression, Surgical/methods , Palliative Care/methods , Ureteral Obstruction/surgery , Urologic Neoplasms/complications , Humans , Prognosis , Ureteral Obstruction/diagnosis , Ureteral Obstruction/etiology , Urography , Urologic Neoplasms/diagnosis
11.
BMJ Case Rep ; 20182018 May 29.
Article in English | MEDLINE | ID: mdl-29844035

ABSTRACT

Keratinising squamous cell metaplasia (KSCM) is an uncommon diagnosis in the West. Patients typically present with lower urinary tract symptoms: haematuria (visible and non-visible), dysuria, urgency and frequency. Investigation is rigid cystoscopy. Abnormal bladder wall tissue should be resected and biopsies sent for histopathology to confirm KSCM. This is a preneoplastic condition with strong associations with squamous cell carcinoma. Due to a significant lag time, annual cystoscopy with multiple biopsies is recommended.


Subject(s)
Carcinoma, Squamous Cell/diagnosis , Cystoscopy/methods , Early Detection of Cancer/methods , Urinary Bladder Neoplasms/diagnosis , Urinary Bladder/pathology , Aged, 80 and over , Biopsy , Carcinoma, Squamous Cell/pathology , Humans , Keratins/analysis , Male , Metaplasia/diagnosis , Metaplasia/pathology , Time Factors , Urinary Bladder Neoplasms/pathology
12.
Urology ; 120: 9-22, 2018 10.
Article in English | MEDLINE | ID: mdl-30403609

ABSTRACT

We systematically assessed the learning curve of Holmium laser enucleation of the prostate using the available literature to identify, as our primary outcome, the average number of cases required to reach competency. A computerized search of PubMed and Scopus for articles published from inception through to January 2018 was performed including 24 studies with a total of 5173 patients. Even though different outcome measures require varying case-loads to reach a plateau, Holmium laser enucleation of prostate has an acceptable learning curve with a proposed figure approximating 25-50 cases, with a structured mentorship programme aiding for faster progress.


Subject(s)
Holmium/therapeutic use , Laser Therapy/methods , Lasers, Solid-State/therapeutic use , Learning Curve , Prostatectomy/methods , Holmium/adverse effects , Humans , Laser Therapy/adverse effects , Lasers, Solid-State/adverse effects , Male , Prostate/surgery , Prostatectomy/adverse effects , Treatment Outcome
13.
BMJ Case Rep ; 20142014 May 02.
Article in English | MEDLINE | ID: mdl-24792024

ABSTRACT

Intravesical BCG immunotherapy is commonly used in the treatment of superficial bladder cancer. We recount the case of an 82-year-old British man who completed a course of BCG immunotherapy in 2011 for superficial bladder cancer, and presented in January 2013 with a loss of appetite, loss of weight and severe back pain. CT scanning, followed by MRI displayed a 5.7 cm × 5 cm conglomerated necrotic, haemorrhagic mass of lymph nodes in the para-aortic region. A CT-guided biopsy revealed granulomatous inflammation, focal fibrosis and acid-fast bacilli consistent with Mycobacterium tuberculosis (TB). The patient was treated with combination antituberculous medication, and is recovering. To our knowledge, this is the only reported case of lymph node TB secondary to intravesical BCG immunotherapy. We suggest that in patients treated with postintravesical BCG with enlarged lymph nodes, a diagnosis of secondary TB should be considered.


Subject(s)
Adjuvants, Immunologic/adverse effects , BCG Vaccine/adverse effects , Carcinoma, Transitional Cell/drug therapy , Mycobacterium tuberculosis/isolation & purification , Tuberculosis, Lymph Node/etiology , Urinary Bladder Neoplasms/drug therapy , Administration, Intravesical , Aged, 80 and over , Humans , Male , Tomography, X-Ray Computed
14.
Gastroenterology Res ; 6(6): 237-239, 2013 Dec.
Article in English | MEDLINE | ID: mdl-27785259

ABSTRACT

Omental torsion is a rare cause of acute abdomen. It usually presents with acute onset right-sided abdominal pain. Adult male between 40 and 50 years of age and obesity are the most common risk factor amongst others. Clinical diagnosis is challenging and difficult to differentiate from more common clinical pathologies such as acute appendicitis and/or acute cholecystitis. Transabdominal imagings such as ultrasonography and/or computed tomography are useful showing typical whirl pattern. Advocated management is surgical excision of torted omentum. Herein, we report a case of primary omental torsion in an adult and a review of current literature. The diagnosis was incidental when patient was undertaken for laparoscopic appendectomy. Only the distal edge of right omentum was torted making a fatty mass of 4 × 3 cm lying on the ascending colon that could have been easily missed if open appendectomy was opted. This case not only highlights the importance of considering torted omentum in differential diagnosis of right-sided abdominal pains but also backs the changing practice to laparoscopic approach for management of right iliac fossa pain.

15.
Int. braz. j. urol ; 43(3): 394-406, May.-June 2017. graf
Article in English | LILACS | ID: biblio-840842

ABSTRACT

ABSTRACT Background Shock wave lithotripsy (SWL) is the first line treatment modality for a significant proportion of patients with upper urinary tracts stones. Simple analgesics, opioids and non-steroidal anti-inflammatory drugs (NSAIDs) are all suitable agents but the relative efficacy and tolerability of these agents is uncertain. Objectives To determine the efficacy of the different types of analgesics used for the control of pain during SWL for urinary stones. Materials and Methods We searched the Cochrane Renal Group’s Specialised Register, MEDLINE, EMBASE and also hand-searched reference lists of relevant articles (Figure-1). Randomised controlled trials (RCT’s) comparing the use of any opioid, simple analgesic or NSAID during SWL were included. These were compared with themselves, each-other or placebo. We included any route or form of administration (bolus, PCA). We excluded agents that were used for their sedative qualities. Data were extracted and assessed for quality independently by three reviewers. Meta-analyses have been performed where possible. When not possible, descriptive analyses of variables were performed. Dichotomous outcomes are reported as relative risk (RR) and measurements on continuous scales are reported as weighted mean differences (WMD) with 95% confidence intervals. Results Overall, we included 9 RCTs (539 participants from 6 countries). Trial agents included 7 types of NSAIDs, 1 simple analgesic and 4 types of opioids. There were no significant differences in clinical efficacy or tolerability between a simple analgesic (paracetamol) and an NSAID (lornoxicam). When comparing the same simple analgesic with an opioid (tramadol), both agents provided safe and effective analgesia for the purpose of SWL with no significant differences. There were no significant differences in pain scores between NSAIDs or opioids in three studies. Adequate analgesia could be achieved more often for opioids than for NSAIDs (RR 0.358; 95% CI 043 to 0.77, P=0.0002) but consumed doses of rescue analgesia were similar between NSAIDs and opioids in two studies (P=0.58, >0.05). In terms of tolerability, there is no difference in post-operative nausea and vomiting (PONV) between the groups (RR 0.72, 95% CI 0.24 to 2.17, P=0.55). One study compared outcomes between two types of NSAIDs (diclofenac versus dexketoprofen). There were no significant differences in any of our pre-defined outcomes measures. Conclusion Simple analgesics, NSAIDs and opioids can all reduce the pain associated with shock wave lithotripsy to a level where the procedure is tolerated. Whilst there are no compelling differences in safety or efficacy of simple analgesics and NSAIDs, analgesia is described as adequate more often for opioids than NSAIDs.


Subject(s)
Humans , Lithotripsy/adverse effects , Urinary Calculi/surgery , Analgesia/methods , Analgesics/administration & dosage , Analgesics, Opioid/administration & dosage , Pain, Postoperative/drug therapy , Analgesics/classification
SELECTION OF CITATIONS
SEARCH DETAIL